Total Payments
$5,741
2024 Payments
$242.65
Companies
40
Transactions
248
Medicare Patients
498
Medicare Billing
$40,973
Payment Breakdown by Category
Food & Beverage$5,298 (92.3%)
Travel$310.33 (5.4%)
Education$133.36 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,298 | 240 | 92.3% |
| Travel and Lodging | $310.33 | 2 | 5.4% |
| Education | $133.36 | 6 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $824.21 | 38 | $0 (2021) |
| Boston Scientific Corporation | $717.61 | 8 | $0 (2019) |
| Amgen Inc. | $484.22 | 6 | $0 (2021) |
| Astellas Pharma US Inc | $400.94 | 15 | $0 (2024) |
| Myovant Sciences Inc. | $398.19 | 21 | $0 (2022) |
| PFIZER INC. | $320.54 | 17 | $0 (2023) |
| Exeltis, USA Inc. | $293.50 | 15 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $272.45 | 15 | $0 (2024) |
| TherapeuticsMD, Inc. | $254.01 | 18 | $0 (2022) |
| Allergan Inc. | $200.66 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $242.65 | 10 | Sumitomo Pharma America, Inc. ($99.39) |
| 2023 | $637.32 | 27 | Exeltis, USA Inc. ($176.21) |
| 2022 | $370.72 | 23 | Myovant Sciences Inc. ($236.08) |
| 2021 | $818.88 | 38 | AbbVie Inc. ($185.64) |
| 2020 | $577.58 | 31 | AbbVie Inc. ($149.84) |
| 2019 | $1,508 | 51 | Boston Scientific Corporation ($705.31) |
| 2018 | $975.08 | 43 | AbbVie, Inc. ($310.97) |
| 2017 | $611.40 | 25 | Amgen Inc. ($96.41) |
All Payment Transactions
248 individual payment records from CMS Open Payments — Page 2 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/08/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: HORMONE THERAPY | ||||||
| 05/31/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: WOMENS HEALTH | ||||||
| 05/04/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Oral Contraceptive | ||||||
| 04/28/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: HORMONE THERAPY | ||||||
| 03/29/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Oral Contraceptive | ||||||
| 03/24/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: Oral Contraceptive | ||||||
| 03/03/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: HORMONE THERAPY | ||||||
| 02/25/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: HORMONE THERAPY | ||||||
| 02/22/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: WOMENS HEALTH | ||||||
| 02/22/2023 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Oral Contraceptive | ||||||
| 01/26/2023 | Exeltis, USA Inc. | TYBLUME (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Oral Contraceptive | ||||||
| 01/10/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: HORMONE THERAPY | ||||||
| 12/15/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: HORMONE THERAPY | ||||||
| 12/02/2022 | Exeltis, USA Inc. | TYBLUME (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Oral Contraceptive | ||||||
| 11/23/2022 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: WOMENS HEALTH | ||||||
| 11/17/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: HORMONE THERAPY | ||||||
| 11/10/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: HORMONE THERAPY | ||||||
| 10/25/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: HORMONE THERAPY | ||||||
| 10/06/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: HORMONE THERAPY | ||||||
| 09/13/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $2.90 | General |
| Category: HORMONE THERAPY | ||||||
| 09/01/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: HORMONE THERAPY | ||||||
| 08/25/2022 | Exeltis, USA Inc. | TYBLUME (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Oral Contraceptive | ||||||
| 07/28/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: HORMONE THERAPY | ||||||
| 07/12/2022 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Oral Contraceptive | ||||||
| 04/19/2022 | Myovant Sciences Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 99 | 134 | $20,887 | $7,299 |
| 2022 | 3 | 122 | 156 | $23,699 | $8,863 |
| 2021 | 3 | 130 | 200 | $32,930 | $12,255 |
| 2020 | 4 | 147 | 215 | $37,949 | $12,555 |
Total Patients
498
Total Services
705
Medicare Billing
$40,973
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 82 | $13,940 | $4,893 | 35.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 39 | 39 | $3,697 | $1,480 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 13 | $3,250 | $926.03 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 98 | $16,255 | $5,922 | 36.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 44 | 44 | $3,916 | $1,708 | 43.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $3,528 | $1,233 | 35.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 86 | 156 | $26,277 | $9,729 | 37.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 17 | $4,250 | $1,462 | 34.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 27 | 27 | $2,403 | $1,064 | 44.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 92 | 157 | $26,447 | $8,749 | 33.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 22 | 25 | $6,383 | $1,985 | 31.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $3,024 | $987.38 | 32.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 21 | 21 | $2,095 | $833.89 | 39.8% |
About Dr. Robert Salk, DO
Dr. Robert Salk, DO is a Obstetrics & Gynecology healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548280555.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Salk, DO has received a total of $5,741 in payments from pharmaceutical and medical device companies, with $242.65 received in 2024. These payments were reported across 248 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($5,298).
As a Medicare-enrolled provider, Salk has provided services to 498 Medicare beneficiaries, totaling 705 services with total Medicare billing of $40,973. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Warwick, RI
- Active Since 07/20/2006
- Last Updated 08/15/2018
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1548280555
Products in Payments
- SOLYX (Device) $705.31
- MYFEMBREE (Drug) $605.73
- Prolia (Biological) $325.60
- PREMARIN (Drug) $273.03
- Orilissa (Drug) $257.47
- Lupron (Drug) $231.26
- SLYND (Drug) $230.60
- LO LOESTRIN FE (Drug) $215.04
- ANNOVERA (Drug) $167.56
- EVENITY (Biological) $158.62
- Veozah (Drug) $151.32
- ORILISSA (Drug) $149.84
- MYRBETRIQ (Drug) $141.35
- INTRAROSA (Drug) $133.36
- Xulane (Drug) $125.70
- Kyleena (Drug) $119.94
- MYOSURE TISSUE REMOVAL DEVICE (Device) $106.06
- ELIQUIS (Drug) $93.49
- SOLOSEC (Drug) $90.92
- Myrbetriq (Drug) $88.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Warwick
Mauro Colavita, Md, MD
Obstetrics & Gynecology — Payments: $24,900
Obstetrics & Gynecology $24,900
Jyothi Rangadhama, M.d, M.D
Obstetrics & Gynecology — Payments: $4,036
Obstetrics & Gynecology $4,036
Dr. Bethany Wortman, Md, MD
Obstetrics & Gynecology — Payments: $2,720
Obstetrics & Gynecology $2,720
Lisa Harrington, Md, MD
Obstetrics & Gynecology — Payments: $2,173
Obstetrics & Gynecology $2,173
Luce Kassi, Md, MD
Obstetrics & Gynecology — Payments: $1,507
Obstetrics & Gynecology $1,507
Dr. Stephanie Zeszutek, Do, DO
Obstetrics & Gynecology — Payments: $835.66
Obstetrics & Gynecology $835.66